Financial News
SEC complaint filed against Natera over promotion of prenatal screening technology
January 14, 2022 at 18:12 PM EST
A complaint to the SEC alleges that Natera misled investors and others about its prenatal screening product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
